GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Nortem Biogroup (XPAR:MLBIO) » Definitions » Price-to-Owner-Earnings

Nortem Biogroup (XPAR:MLBIO) Price-to-Owner-Earnings : (As of Sep. 23, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Nortem Biogroup Price-to-Owner-Earnings?

As of today (2024-09-23), Nortem Biogroup's share price is €5.40. Nortem Biogroup does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for Nortem Biogroup's Price-to-Owner-Earnings or its related term are showing as below:


XPAR:MLBIO's Price-to-Owner-Earnings is not ranked *
in the Consumer Packaged Goods industry.
Industry Median: 15.84
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-09-23), Nortem Biogroup's share price is €5.40. Nortem Biogroup does not have enough years/quarters to calculate the Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023. Therefore GuruFocus does not calculate PE Ratio at this moment.

As of today (2024-09-23), Nortem Biogroup's share price is €5.40. Nortem Biogroup does not have enough years/quarters to calculate the EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023. Therefore GuruFocus does not calculate PE Ratio without NRI at this moment.

During the past 3 years, Nortem Biogroup's highest PE Ratio without NRI was 37.50. The lowest was 27.84. And the median was 37.50.


Nortem Biogroup Price-to-Owner-Earnings Historical Data

The historical data trend for Nortem Biogroup's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nortem Biogroup Price-to-Owner-Earnings Chart

Nortem Biogroup Annual Data
Trend Dec21 Dec22 Dec23
Price-to-Owner-Earnings
- - -

Nortem Biogroup Semi-Annual Data
Dec21 Dec22 Dec23
Price-to-Owner-Earnings - - -

Competitive Comparison of Nortem Biogroup's Price-to-Owner-Earnings

For the Packaged Foods subindustry, Nortem Biogroup's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nortem Biogroup's Price-to-Owner-Earnings Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Nortem Biogroup's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Nortem Biogroup's Price-to-Owner-Earnings falls into.



Nortem Biogroup Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Nortem Biogroup's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=5.40/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nortem Biogroup  (XPAR:MLBIO) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Nortem Biogroup Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Nortem Biogroup's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Nortem Biogroup Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Calle Alexander Humboldt 12B, Polígono Industrial Salinas de Poniente, El Puerto de Santa María, Cadiz, ESP, 11500
Nortem Chem SA is engaged in the research, development, innovation and industrialization in the field of biochemistry and biotechnology, as well as the production and sale of products based on biochemical and/or biotechnological processes. It emerged as a biotechnological company in the field of the food and chemical industry, with maximum environmental awareness, concentrating its research and product development efforts on the development of environmentally friendly alternatives from renewable sources and obtaining its own microorganisms (Aspergillus Niger and Yarrowia lipolytica) with outstanding capabilities from adaptation and selection processes, avoiding the use of genetic modification technologies.

Nortem Biogroup Headlines

No Headlines